Accretive Wealth Partners’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.42M | Buy |
15,859
+171
| +1% | +$26.1K | 0.79% | 39 |
|
|
2025
Q1 | $2.42M | Buy |
15,688
+4,424
| +39% | +$683K | 0.86% | 36 |
|
|
2024
Q4 | $1.63M | Sell |
11,264
-8
| -0.1% | -$1.16K | 0.69% | 50 |
|
|
2024
Q3 | $1.83M | Sell |
11,272
-1,229
| -10% | -$199K | 0.76% | 43 |
|
|
2024
Q2 | $1.83M | Buy |
12,501
+680
| +6% | +$99.4K | 0.76% | 38 |
|
|
2024
Q1 | $1.76M | Buy |
11,821
+164
| +1% | +$24.5K | 0.78% | 39 |
|
|
2023
Q4 | $1.83M | Sell |
11,657
-16
| -0.1% | -$2.51K | 0.88% | 33 |
|
|
2023
Q3 | $1.82M | Sell |
11,673
-165
| -1% | -$25.7K | 1.08% | 22 |
|
|
2023
Q2 | $1.96M | Sell |
11,838
-187
| -2% | -$31K | 1.16% | 19 |
|
|
2023
Q1 | $1.86M | Buy |
12,025
+133
| +1% | +$20.6K | 1.19% | 17 |
|
|
2022
Q4 | $2.1M | Buy |
11,892
+767
| +7% | +$135K | 1.44% | 15 |
|
|
2022
Q3 | $1.82M | Buy |
11,125
+3
| +0% | +$490 | 1.38% | 17 |
|
|
2022
Q2 | $1.97M | Buy |
11,122
+31
| +0.3% | +$5.5K | 1.43% | 16 |
|
|
2022
Q1 | $1.97M | Buy |
11,091
+176
| +2% | +$31.2K | 1.23% | 18 |
|
|
2021
Q4 | $1.87M | Buy |
10,915
+366
| +3% | +$62.6K | 1.19% | 19 |
|
|
2021
Q3 | $1.7M | Buy |
10,549
+627
| +6% | +$101K | 1.2% | 17 |
|
|
2021
Q2 | $1.64M | Buy |
9,922
+3,279
| +49% | +$540K | 1.18% | 17 |
|
|
2021
Q1 | $1.09M | Buy |
6,643
+325
| +5% | +$53.4K | 0.98% | 31 |
|
|
2020
Q4 | $994K | Buy |
+6,318
| New | +$994K | 0.98% | 30 |
|